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ABSTRACT The innate immune systems of humans and other animals are activated by lipopolysaccharides (LPS), which are
glucosamine-based phospholipids that form the outer leaﬂet of the outer membranes of Gram-negative bacteria. Activation
involves interactions of LPS with the innate immunity-receptor comprised of toll-like receptor 4 in complex with so-called MD-2
protein and accessory proteins, such as CD14 and LPS binding protein. The Lipid Metabolites and Pathways Strategy (LIPID
MAPS) Consortium has isolated in large amounts a nearly homogeneous LPS, Kdo2-Lipid A, and demonstrated that it activates
macrophages via toll-like receptor 4. The active form of LPS, monomer or aggregate, is controversial. We have therefore
examined the aggregation behavior and other physical properties of Kdo2-Lipid A. Differential scanning calorimetry of Kdo2-
Lipid A suspensions revealed a gel-to-liquid crystalline phase transition at 36.4C (Tm). The nominal critical aggregation
concentration, determined by dynamic light scattering, was found to be 41.2 6 1.6 nM below the Tm (25C), but only 8.1 6
0.3 nM above the Tm (37C). The speciﬁc molecular volume of Kdo2-Lipid A, obtained by densitometry measurements was
found to be 3159 6 71 A˚3 at 25C, from which the number of molecules in each aggregate was estimated to be 5.8 3 105. The
aggregation behavior of Kdo2-Lipid A in the presence of lipoprotein-deﬁcient serum suggests that Re LPS monomers and
multimers are the active units for the immune system in the CD14-dependent and -independent pathways, respectively.
INTRODUCTION
Lipopolysaccharide (LPS) is an amphiphilic glucosamine-
based phospholipid found on the outer leaflet of the outer
membranes of most Gram-negative bacteria (1,2). LPS acti-
vates the immune system in mammals and is considered to
play a key role in human septic shock syndrome (1,3), one of
the major causes of death in U.S. intensive-care units (4).
Recent studies on the mechanism of LPS-induced im-
munostimulation have significantly advanced our under-
standing of protein linkage in the signaling pathway (5–7)
and focused attention on the roles of monomeric and multi-
meric forms of LPS in immune activation (8–10). Here we
report the results of a study of the aggregation behavior and
other properties of an exceptionally pure monomolecular
LPS species known as Kdo2-Lipid A, which has recently
been shown to activate macrophages via TLR-4 (11).
LPS first associates with LPS binding protein (LBP), an
acute-phase protein in serum, and is then transferred to the
complex of toll-like receptor 4 (TLR-4) and its co-receptor
MD-2 with or without the help of CD14, which is a glyco-
sylphosphatidylinositol-linked protein expressed on the mac-
rophage surface (mCD14) that also exists in a soluble form in
serum (sCD14) (12–14). The binding of LPS to TLR-4/MD-2
complex initiates transmembrane signaling via Toll-interleukin
1 receptors, such as myeloid differentiation primary response
protein (MyD88), MyD88-like adaptor, TIR-domain-
containing adaptor-inducing interferon-b (TRIF), and TRIF-
related adaptor molecule. The resulting signals lead to the
production of proinflammatory cytokines, including tumor
necrosis factor (TNF) and interferon-b (13,15). Depending on
the type of recognition, mCD14-dependent or -independent,
downstream signaling can be switched between MyD88-
dependent and -independent pathways (13,16).
The chemical structure of LPS varies among different
species of bacteria, with each species expressing a number of
structurally heterogeneous LPSs (17–21). A feature common
to the LPS molecules is a hydrophilic polysaccharide at-
tached to a hydrophobic endotoxic principle termed Lipid A.
Wild-type bacterial strains express LPS composed of a
nonrepeating core oligosaccharide and a distal polysacchar-
ide (O-antigen). LPS of so-called rough mutant strains do not
have the O-antigen, but, instead, only 2–15 core oligosac-
charides (22), which are characterized by chemotypes with
decreasing lengths of the core sugar, known as Ra, Rb, Rc,
Rd, and Re (19). The amphiphilic nature of LPS promotes the
formation of aggregates above a critical concentration. Be-
cause of the high solubility of the oligosaccharide moiety, the
critical concentration can be in the nanomolar range (10).
The answer to the fundamental question of whether the
active form of LPS is a monomer or a multimer has been
controversial. Takayama et al. (10) reported that a dis-
aggregated form of Re LPS from Escherichia coli was more
active in stimulating 70Z/3 cells (a LPS-responsive murine
pre-B cell line) than the aggregated form. Also, they showed
that monomeric LPS induced production of Egr-1 mRNA
from thioglycolate-elicited murine peritoneal macrophages
1000-fold more efficiently than aggregated LPS. Further-
more, monomeric Re LPS from E. coli was 179-fold more
active than aggregates in the Limulus amebocyte lysate assay
(9). On the other hand, Mueller et al. found that Re LPS and
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Lipid A of E. coli displayed their activities only in multimeric
form in the Limulus amebocyte lysate assay and proin-
flammatory production of TNF-a from human mononuclear
cells (8).
The aggregation behaviors of various LPS species have
been examined by means of fluorescence spectroscopy
(23,24), light scattering (25), and equilibrium dialysis
(9,10,23,26) (see review by Brandenburg et al. (27)). The
most complete and accurate study is that of Santos et al. (25),
who used light scattering to determine the aggregation be-
havior of a wild-type LPS from E. coli serotype 026:B6.
Their work revealed that 026:B6 progresses through three
states as LPS concentration is increased: monomers; pre-
aggregate oligomers; and large aggregates (Fig. 1 A). The
hydrodynamic radii of preaggregate oligomers and large
aggregates were determined to be 60 nm and 95 nm, re-
spectively, but as for all previous studies, the LPS they used
was chemically heterogeneous in terms of the length and
composition of the terminal glycan chains (1,17,18,22).
Recently, a large-scale methodology for preparation of an
ultra-pure and chemically homogeneous LPS with two core
sugars (Kdo2-Lipid A), one that has the same general struc-
ture as the Re LPS from E. coli (Fig. 1 B), has been reported
by the LIPID MAPS Consortium (11) (www.lipidmaps.org).
We report here the temperature-dependent change in the
transition between monomeric and preaggregate oligomer
phase of Kdo2-Lipid A, determined using dynamic light
scattering. We also determined the partial specific volume of
Kdo2-Lipid A from which we estimated the aggregation
number of the preaggregate oligomers. Finally, by comparing
the multimerization behavior of Kdo2-Lipid A in the pres-
ence of lipoprotein-depleted serum with published im-
munostimulation data, we surmise that Re LPS monomers
and multimers are likely the active units for the immune




Pure Kdo2-Lipid A was prepared as the tetra-ammonium salt (.99%) by
Avanti Polar Lipids (Alabaster, AL) for the LIPIDMAPS project. The lipid is
commercially available from Avanti. Lipoprotein-deficient fetal bovine
serum (FBS), which contains ,5% of normal lipoproteins, was obtained
from Sigma Chemical (St. Louis, MO). Dulbecco’s modified Eagle’s me-
dium (DMEM) and Dulbecco’s PBS (DPBS) buffer without Ca21 and Mg21
were purchased from HyClone (Logan, UT). All chemicals were used as
purchased without further purification.
FIGURE 1 The aggregation states of LPS and the struc-
ture of Kdo2-Lipid A. (a) Schematic illustration of mor-
phological change of LPS as a function of concentration.
The critical concentrations for the transitions between
monomer-preaggregate oligomer and between preaggregate
oligomer-large aggregate are defined as CMC and CMCa,
respectively. (b) Chemical structure of Kdo2-Lipid A,
which has the same general structure as Re LPS from E.
coli. Native bacteria generally produce structurally hetero-
geneous LPS, but Kdo2-Lipid A is a homogeneous LPS
isolated by the LIPID MAPS Consortium (11).
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Sample preparation
For differential scanning calorimetry (DSC) and dynamic light-scattering
experiments, Kdo2-Lipid A was hydrated in DPBS buffer (pH 7.2) to make a
10 mM suspension. The suspension was homogenized by vortexing, fol-
lowed by 10 freeze (78C)/thaw (65C) cycles. The lipid sample was then
extruded with a thermobarrel extruder (Northern Lipids, Vancouver, British
Columbia, Canada) 10 times through two stacked 0.2 mm Nucleopore poly-
carbonate membranes (Whatman, Florham Park, NJ) under N2 pressure of
250 psi at 65C (28,29). This extruded suspension of Kdo2-Lipid A (10 mM)
was proved to be large unilamellar vesicles by using the quenching system
with 8-aminonaphthalene-1,3,6-trisulfonic acid (ANTS) and p-xylene-bis-
pyridinium bromide (30–32). The fluorescent ANTS was quenched by
p-xylene-bis-pyridinium bromide within Kdo2-Lipid A vesicles, but the
leakage of vesicle contents induced by a detergent (Triton X-100) caused an
increase in ANTS fluorescence due to dilution into the extravesicular space
(data not shown). Previous reports on the aggregation behavior of LPS re-
vealed that the transition from the preaggregate oligomer phase to the large
aggregate phase occurs in the micromolar range (23,25). Hence, this fluo-
rophore-leakage result at 10 mM demonstrates that Kdo2-Lipid A exists as
vesicles in the large aggregate phase.
Lipid concentrations of the extruded lipid were determined according to
the procedure of Bartlett (33). Samples for DSC measurements were pre-
pared by diluting the extruded stock dispersion with DPBS buffer (pH 7.2).
For light scattering experiments, we used two procedures for preparation of
solutions/dispersions of Kdo2-Lipid A at various concentrations to assure
that data were collected for Kdo2-Lipid A in reversible states. In the first
(dilutionmethod), several concentrations were made by diluting the extruded
stock dispersion with prefiltered (0.2 mm pore) DPBS buffer (pH 7.2) or
DMEM with 0.5% (v/v) lipoprotein-deficient FBS. In the second (addition
method), appropriate amounts of the stock solution of Kdo2-Lipid A (60 mg/
mL) in chloroform-methanol (2:3 v/v) was added to a vial. After evaporation
of the solvent under a stream of nitrogen, an appropriate volume of prefiltered
DPBS (pH 7.2) was added to the residual pellet and vortexed for 5 min.
For densitometry experiments, Kdo2-Lipid A was carefully weighed on a
Mettler H54 balance, and suspended in water. The suspension was homog-
enized by vortexing, followed by 10 freeze (78C)/thaw (65C) cycles.
DSC measurements
DSCmeasurementswere performed on aMicroCal VP-DSCMicroCalorimeter
(Northampton, MA). Three scans were carried out between 5 and 60C with
a scanning rate of 0.2C/min, and the data of the third scan were collected.
DSC data were corrected by subtraction of suitable control data for deter-
mination of the gel-to-liquid-crystalline transition temperature.
Dynamic light scattering measurements
Dynamic light scattering measurements at room temperature (;25C) and
37C were performed on a Wyatt Technology (Santa Barbara, CA) DAWN
EOS (laser wave length: 690 nm) and aWyatt Technology DAWNHELEOS
(laser wave length: 658 nm), respectively. Samples (1 mL) were injected into
an internal flow cell for 15min and the residual flow allowed to stop. Samples
were then equilibrated at each temperature for at least 2 h before data col-
lection. Three measurements were made for each sample at each temperature.
The measured intensity of scattered light from each sample was normalized
to that of DPBS buffer (pH 7.2) or DMEM. The mean decay rate G was
determined by fitting the intensity-intensity correlation function g(2)(t) to the
equation
g
ð2ÞðtÞ ¼ B1b expð2GtÞð11m2t2=2!Þ2;
where B is the baseline, b is a factor that depends on the experimental
geometry, and m2 is the variance of distribution of G (34,35). The averaged
hydrodynamic radius (Rh) was determined from G by using the Stokes-
Einstein equation
Rh ¼ kBT=ð6phDÞ:
The diffusion constant D was calculated using
G ¼ Dq2;
in which
q ¼ ð4pn0=l0Þ sinðu=2Þ:
In this equation, n0 is the refractive index of the solvent, l0 is the wavelength
of the laser, u is the scattering angle, kB is the Boltzmann constant, T is the
absolute temperature, and h is the viscosity of the solvent. Size distribution
analyses were performed with the software ASTRA V (Wyatt Technology).
Densitometry measurements
Density of the lipid solution (dsolution) was determined with a DMA 10 digital
precision density meter (Anton Paar, Graz, Austria) by measuring the natural
frequency of a hollow oscillator. For calibration of the densitometer, air
(dair¼ 1.1843 103 g/cm3, 25C, 1 atm) and water (dwater¼ 0.99707 g/cm3,
25C, 1 atm) were used. Measurements were performed three times at room
temperature. The specific density of the lipid (dL) can be written as
dL ¼ WL=½ðWwater1WLÞ=dsolution Wwater=dwater;
where WL and Wwater are the masses of the lipid and water, respectively.
Specific molecular volume of the lipid (VL) was determined from dL from
VL ¼ Mw=ðdLNAÞ;
whereMw is the molecular weight of the lipid andNA is Avogadro’s number.
RESULTS
Fig. 2 shows the DSC heating trace of Kdo2-Lipid A. In
addition to a main peak at 36.4C (Tm), which corresponds to
the gel-to-liquid crystalline phase transition, another minor
peak was observed as a shoulder at 33.2C.
The aggregation behavior of Kdo2-Lipid A prepared by
both the dilution and addition methods (see Materials and
Methods) was examined by dynamic light scattering. Dy-
namic light scattering data from the samples were analyzed
by the cumulants method (Fig. 3), which provides the hy-
drodynamic radius (Rh) and a parameter that correlates with
the polydispersity of the solution (m2) (the higher m2, the
higher the polydispersity). As described in the report by
Santos et al. (25), aggregation can be characterized by the
increase in hydrodynamic radius and/or the decrease in
polydispersity parameter. Fig. 3 shows that m2 increases over
the same range (,200 nM) regardless of the preparation
method. Changes in Rh at,200 nM reveal that the transition
of Kdo2-Lipid A from the monomeric phase to the pre-
aggregate oligomer phase occurred below 200 nM at room
temperature (Fig. 4 a). The aggregation process in this con-
centration range was found to be highly cooperative by size
distribution analyses of the dynamic light scattering data. At
concentrations of 20 and 50 nM, monomers (Rh , ;1 nm)
coexisted with intermediate oligomers, whose sizes increased
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as a function of concentration from Rh; 4 nm to ;30 nm.
(Fig. 4, b and c). At 100 nM, the monomer peak disappeared
from distribution histogram (Fig. 4 d ). The radius of the
steady-state preaggregate oligomers of Kdo2-Lipid A is;73
nm (Fig. 4 a), which is only slightly smaller than the nominal
radius of the LUV aggregates (;100 nm). The size of large
unilamellar vesicles could not be determined directly by our
light scattering instrument, because the concentration at
which vesicles were prepared (10 mM; see Materials and
Methods) was so high that strongly scattered light from
Kdo2-Lipid A was beyond the observable range.
To determine the approximate number of Kdo2-Lipid A
molecules in the preaggregates, we determined the specific
molecular volume (VL) of Kdo2-Lipid A in water. A general
method for determining absolute specific volumes of lipids is
the neutral density procedure, carried out using H2O/D2O
mixtures (36–40). But this method was not appropriate for
Kdo2-Lipid A, because the lipid was found to be denser than
D2O (dD2O[25C] ¼ 1.10445 g/cm3). We therefore used a
digital density meter to obtain the specific density (dL) of the
lipid. The numerical values of dL and VL were determined to
be 1.21 6 0.03 g/cm3 and 3159 6 71 A˚3, respectively, at
room temperature. Assuming that Kdo2-Lipid A is approxi-
mately spherical, we estimated the apparent radius Rmonomer
0.91 6 0.01 nm. Assuming that the preaggregate oligomers
of Kdo2-Lipid A are micelles or multilamellar vesicles, we
calculated from Rmonomer the aggregation number (N) of
steady-state preaggregate oligomers at room temperature to
be ;5.8 3 105 (Fig. 4 a). Rmonomer was also used to obtain
simulated sigmoidal curves combined with the dynamic light
scattering data, shown in Fig. 5.
Because biological experiments (e.g., cell stimulation) are
usually carried out at the physiological temperature of 37C,
we compared the light scattering curves of Kdo2-Lipid A at
25 and 37C (Fig. 5). Although Rmonomer of Kdo2-Lipid A at
37C is probably larger than at 25C because of greater
disorder of the hydrocarbon chains, the 25C value of
Rmonomer was used for sigmoidal fitting, because the differ-
ence in the monomer size at different temperatures should
be negligible compared to the size change accompanying
multimerization. At 37C, the concentration at which half-
multimerization occurs (C50) is 8.16 0.3 nM, which is lower
than at 25C (41.2 6 1.6 nM). Furthermore, the radii of
preaggregate oligomers were 23% larger (Rh ¼ 95 nm) than
those at 25C.
The measurements at 37C provide a starting point for
examining the question of whether the active form of LPS is a
monomer or a multimer in cell stimulation experiments. This
is a complicated issue, because such experiments are carried
out in media containing blood serum, which is rich in lipo-
proteins. These lipoproteins create two problems. First, they
strongly scatter light and, second, they strongly adsorb LPS
(41). (Only LPSs not bound to lipoproteins can stimulate the
immune system (42).) As a first step, we carried out dynamic
light scattering measurements of Kdo2-Lipid A in the pres-
ence of lipoprotein-deficient serum. Fig. 6 shows the multi-
merization behavior of Kdo2-Lipid A in Dulbecco’s modified
Eagle’s medium (DMEM) in the presence of 0.5% (v/v) fetal
bovine serum (FBS) that lacks lipoproteins at 37C. This FBS
concentration minimizes the intense light scattering from
numerous FBS proteins, such as albumin and globulin, which
readily mask light scattering due to Kdo2-Lipid A. The
apparent Rh of the lipoprotein-deficient FBS without Kdo2-
Lipid A was found to be ;5.4 nm. Surprisingly, multi-
FIGURE 2 DSC heating trace of Kdo2-Lipid A (1 mM) in DPBS (pH 7.2).
The relatively sharp peak is consistent with the purity and chemical
homogeneity of Kdo2-Lipid A. The principal phase transition temperature
(Tm) was determined to be 36.4C. The minor peak at 33.2C that appears as
a shoulder of the main peak may be due to a pretransition of the alkyl chains.
FIGURE 3 Change in variance of distributions (m2) at room temperature
(;25C) of Kdo2-Lipid A prepared by the dilution and addition methods.
The data for the dilution and addition methods are depicted by solid and
open circles, respectively. Aggregation is indicated by the decrease in the
polydispersity parameter (25). These data show that aggregation of Kdo2-
Lipid A is independent of method of preparation.
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merization in the presence of lipoprotein-deficient FBS
occurred at higher concentration than in DPBS buffer:
Kdo2-Lipid A began to form multimers at ;6 nM and C50
was 292 6 29 nM (Fig. 6).
DISCUSSION
The natural structural heterogeneity of LPS generally pro-
duced by bacteria has hampered accurate physical charac-
terization of the lipids. The availability of Kdo2-Lipid A has
made it possible for us to examine, for the first time to our
knowledge, the physical properties of a chemically homo-
geneous LPS. DSC thermograms obtained from Re LPSs
from Salmonella minnesota serotype Re595 and E. coli
showed very broad peaks (43,44) because of the chemical
heterogeneity. The DSC thermogram of Kdo2-Lipid A
heating scan, on the other hand, was composed of sharp peaks
due to the purity and structural homogeneity of the lipid (Fig.
2). The main transition temperature (Tm) is consistent with
the reported values for b4a transitions of various LPSs,
which lie in the range 30–40C (27). We did not perform any
structural analyses to characterize the minor transition at
33.2C, but considering that the fatty acyl chains of Kdo2-
Lipid A are composed of five 14:0 chains and one 12:0 chain
(Fig. 1 B), the minor peak may correspond to the gel (Lb9)-
rippled gel (Pb9) transition (pretransition) of hydrocarbon
chains, because phosphatidylcholines with 13:0 or longer
acyl chains are known to have pretransitions below the gel
FIGURE 4 Aggregation behavior of Kdo2-Lipid A. (a) Hydrodynamic radii (Rh; solid circles, left axis) and aggregation numbers (N; open circles, right axis)
of Kdo2-Lipid A in DPBS (pH 7.2) at different concentrations at room temperature (;25C). The letters refer to neighboring panels. Below 200 nM Kdo2-
Lipid A, Rh increased accompanying the transformation of monomers into preaggregate oligomers. The steady-state radius of preaggregate oligomers was 73
nm. Compared with Fig. 3, the multimerizing range (,200 nM) revealed by the change of Rh was consistent with that shown by m2. Aggregation numbers were
calculated from the hydrodynamic radii and the specific molecular volume of Kdo2-Lipid A (3159 6 71 A˚
3) obtained by densitometry measurements. The
aggregation number of the preaggregate oligomers in steady state was determined to be 5.83 105. (b–d ) Size-distribution analysis histograms that demonstrate
particle-size distributions during aggregation at room temperature. The histograms at concentrations 20 nM, 50 nM, and 100 nM are depicted in panels b, c, and
d, respectively. These data reveal that the aggregation process of Kdo2-Lipid A is highly cooperative: monomers coexist with intermediate oligomers whose
sizes increase as a function of concentration.
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(Pb9)-to-liquid crystalline phase (La) transition temperature
(45,46). The close proximity of the Lb9-Pb9 and Pb9-La peaks
of Kdo2-Lipid A suggest that the free energy differences
between the Lb9, Pb9, and La phases are quite small.
LPSmonomers are transformed into preaggregate oligomers
above a critical concentration (CMC), and at higher con-
centrations (CMCa) the aggregates form other supramolec-
ular aggregates, which can be multilamellar or nonlamellar
depending on the physicochemical environment (23,25,27)
(Fig. 1 A). CMCa values of various types of LPS lie in themM
concentration range: 3.2 mM (8 mg/mL) for Re LPS from
S. minnesota serotype Re595 (23) and 5.6 mM (14 mg/mL)
for wild-type LPS from E. coli serotype 026:B6 (25). We
carried out dynamic light scattering measurements in sub-
micromolar range (10–800 nM). Hence, our data shown here
demonstrate the multimerization behavior of Kdo2-Lipid A
between monomeric phase and preaggregate oligomer phase
around the CMC. The size of vesicles formed above the
CMCa of Kdo2-Lipid A could not be determined directly by
our light scattering instrument, because the concentration at
which vesicles form (10 mM; see Materials and Methods)
was so high that light scattering from Kdo2-Lipid A was
outside the observable range.
If our light scattering experiments were carried out on
Kdo2-Lipid A in reversible equilibrated states, then the ag-
gregation behavior of Kdo2-Lipid A as a function of concen-
tration should be identical independent of sample preparation
procedure. This was found to be the case. Fig. 3 shows that
preparation of the samples by the dilution and addition
methods give identical results; multimerization of Kdo2-Lipid
A occurred in the identical range (,200 nM) regardless of the
preparation procedure. The radius of preaggregate oligomers
of Kdo2-Lipid A obtained at room temperature (Fig. 4) is 22%
larger than that of wild-type LPS from E. coli serotype 026:B6
at 37C reported by Santos et al. (25).
As far as we can establish, Fig. 5 presents the first dem-
onstration that the transition between monomers and pre-
aggregate oligomers depends upon temperature. At 37C, the
transition began at a 10-fold lower concentration than at
25C: ;0.3 nM at 37C and ;3 nM at 25C. This result
differs from that of equilibrium dialysis data: the solubilities
of Re LPS from E. coli at 22 and 37C were almost constant
at ;30 nM (10). However, determination of solubility by
equilibrium dialysis does not directly measure multimerization,
but rather the maximum concentration at which LPS can be
present as monomers (10).
Direct interpretation of immunostimulation data using bio-
physical LPS multimerization data has been difficult, because
the conditions under which physical and cell stimulation ex-
periments are performed are usually different. For example,
separation of monomeric and multimeric LPS by means of
dialysis has been performed in water or buffer (8,9), while cell
stimulation data were collected in cell-culture medium con-
taining blood serum. This raises the possibility that the critical
aggregation concentration in culture medium could be differ-
ent due to the binding of LPS to serum components such as
LBP, sCD14, and lipoproteins (5,41). LBP and sCD14 are
known to transport LPS to the TLR-4/MD-2 complex and to
lipoproteins (42). The LPS that binds to TLR-4/MD-2 com-
FIGURE 5 Sigmoidal light scattering curves of Kdo2-Lipid A in DPBS
(pH 7.2) at 25C and 37C. These curves were obtained from the dynamic
light scattering data and densitometry measurements. The transition between
monomers and preaggregate oligomers at 37C began at a 10-fold lower
concentration than at 25C: ;0.3 nM at 37C and ;3 nM at 25C. The
concentrations at which half-multimerization occurs (C50s) were determined
to be 41.2 6 1.6 nM (25C) and 8.1 6 0.3 nM (37C). The radius of the
preaggregate oligomers in steady state (37C) was 95 nm.
FIGURE 6 Hydrodynamic radii (Rh) of Kdo2-Lipid A in DMEM con-
taining 0.5% (v/v) fetal bovine serum (FBS) deficient in lipoproteins at
different concentrations at 37C. These data show that multimerization
begins at;6 nM and that the C50 was 2926 29 nM in the presence of FBS.
The interaction of Kdo2-Lipid A with serum components such as LPS
binding protein (LBP) and sCD14 probably shifted the critical multi-
merization concentration (CMC) higher compared to that in DPBS shown
in Fig. 5.
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plex generates inflammatory responses, but the lipoprotein-
bound LPS loses its biological activity (42). The LPS added to
serum, therefore, exists as immunostimulative lipoprotein-
unbound form or detoxified lipoprotein-bound form. The ratio
of the numbers of these two forms has been reported to change
depending on time after incorporation into the immune sys-
tem: LPS incubated with normal human plasma for ,10 min
accelerated activation of polymorphonuclear leukocytes, while
a longer period of incubation (.40 min) resulted in a de-
crease in stimulation (47). This observation suggests that
unbound LPS is the predominant form until LPS is gradually
transferred to lipoproteins. This means that conclusions about
the active form of LPS should be based upon the aggregation
behavior of LPS in the presence of serum before the binding
to lipoproteins. Fig. 6 demonstrates that the multimerization
in the presence of lipoprotein-deficient FBS occurred at
36-fold higher concentration than in DPBS buffer, probably
due to the interaction of Kdo2-Lipid A with LBP and sCD14.
Thus one expects that, for FBS with full lipoprotein content,
multimerization will occur at an even higher concentration.
There are two modes of LPS recognition by the TLR-4/
MD-2 complex: mCD14-dependent and -independent rec-
ognition (13,14). Depending on the type of recognition,
downstream signaling pathways can be switched between
MyD88-dependent and -independent pathways (13,16). Re-
cently, Gangloff et al. (48) examined the TNF-a response of
thioglycolate-elicited peritoneal macrophages from normal
mice or mCD14-deficient mice, after stimulation with vari-
ous types of LPS in the presence of 1% autologous serum.
They found that murine macrophages with mCD14 started to
produce TNF-a in the presence of;0.04 nM of Re LPS from
E. coli at 37C, whereas macrophages without mCD14 did
not start TNF-a production until the concentration of the lipid
increased as much as;4 nM (48). Our results, shown by the
curve in Fig. 6, suggest that the multimeric form of Re LPS
may exist before transfer to lipoproteins in the presence of
0.5% (v/v) FBS if the LPS concentrations are higher than;6
nM. Although the conditions under which our light scattering
measurements were performed are not exactly the same as for
the cell stimulation experiments of Gangloff et al., Fig. 6 is
consistent with the idea that Re LPS monomers stimulate the
mCD14-dependent pathway and Re LPSmultimers stimulate
the mCD14-independent pathway.
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